symmetric dimethylarginine has been researched along with Lymphoma, Non-Hodgkin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biedroń, M; Butrym, A; Chachaj, A; Fleszar, MG; Gamian, A; Karczewski, M; Krzystek-Korpacka, M; Mazur, G; Rybka, J; Szuba, A; Wiśniewski, J; Wróbel, T | 1 |
1 other study(ies) available for symmetric dimethylarginine and Lymphoma, Non-Hodgkin
Article | Year |
---|---|
Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers, Tumor; Case-Control Studies; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Prospective Studies; Survival Rate; Young Adult | 2018 |